Clinical Trials on Smartphone-application in Australia

Total 4 results

  • Novartis Pharmaceuticals
    Completed
    A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
    Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 Mutation
    France, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
  • BioCeryx
    University of British Columbia; University College London Hospitals; Brugmann... and other collaborators
    Unknown
    Automated Screen for Fetal Aneuploidy (FAST1)
    Trisomy 21 and Other Fetal Aneuploidy
    Australia, United Kingdom, Spain, Canada, Belgium, Portugal
  • Women and Infants Hospital of Rhode Island
    Sequenom, Inc.
    Completed
    A New Prenatal Blood Test for Down Syndrome (RNA)
    Down Syndrome | Trisomy 21
    United States, Canada, Israel, Hungary, Ireland, Argentina, Australia, Czech Republic, Italy, Spain
  • Natera, Inc.
    Children's Hospital of Philadelphia; Montefiore Medical Center; University of... and other collaborators
    Completed
    SNP-based Microdeletion and Aneuploidy RegisTry (SMART) (SMART)
    Prader-Willi Syndrome | DiGeorge Syndrome | 22q11 Deletion Syndrome | Angelman Syndrome | Trisomy 21 | Trisomy 18 | Trisomy 13 | Monosomy X | Sex Chromosome Abnormalities | 1p36 Deletion Syndrome | Cri-du-Chat Syndrome
    United States, Australia, Ireland, Spain, Sweden, United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe